Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA
1969452 citationsG Mathé, Jeanne Amiel et al.profile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
This map shows the geographic impact of G Mathé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Mathé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Mathé more than expected).
This network shows the impact of papers produced by G Mathé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Mathé. The network helps show where G Mathé may publish in the future.
Co-authorship network of co-authors of G Mathé
This figure shows the co-authorship network connecting the top 25 collaborators of G Mathé.
A scholar is included among the top collaborators of G Mathé based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with G Mathé. G Mathé is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Mathé, G & R. Hulhoven. (1982). Vindesine in Leukemia and Non-hodgkin Lymphoma. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 8(5). 555–558.1 indexed citations
5.
Bonadonna, G., et al.. (1979). Adjuvant therapies of the various primary tumors. Springer eBooks.2 indexed citations
6.
Rappaport, Henry, et al.. (1979). Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 96(1). 121–42.75 indexed citations
7.
Hallé-Pannenko, O, et al.. (1978). Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells.. PubMed. 29(7). 253–5.20 indexed citations
8.
Tubiana, M, et al.. (1977). [Treatment of clinical stages I and II of Hodgkin's disease].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(2). 463–72.1 indexed citations
9.
Mathé, G. (1976). How far are in vivo models of experimental medicine valid for human medicine?. PubMed. 24(4). 225–6.1 indexed citations
10.
Mathé, G & L Schwarzenberg. (1976). Treatment of bone marrow aplasia by bone marrow graft after conditioning with antilymphocyte globulin. Long term results.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(4). 256–64.14 indexed citations
11.
Mathé, G, D Belpomme, D Dantchev, & P Pouillart. (1975). Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).. PubMed. 22(3). 177–85.16 indexed citations
12.
Mathé, G & Y. Kenis. (1973). Logistics of therapeutic trials: the example of cancerology.. PubMed. 18(3). 181–4.1 indexed citations
13.
Mathé, G, L Schwarzenberg, Maham Hayat, & M Schneider. (1968). [Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].. PubMed. 13(10). 951–60.3 indexed citations
14.
Sekiguchi, Miho, et al.. (1966). Investigation on a test of histocompatibility for allogeneic grafts. 3. A study in man.. PubMed. 4(2). 206–8.5 indexed citations
15.
Mathé, G, Jeanne Amiel, & Charlotte Friend. (1962). Essai de traitement de la leucemie de charlotte friend par la greffe de cellules hematopoietiques de donneurs isogeniques vaccines contre le virus.. The Mouseion at the JAXlibrary (Jackson Laboratory).3 indexed citations
16.
Mathé, G, et al.. (1961). Etude en microscopie optique et electronique des 'cellules immunolo- giquement competentes' au cours des reactions de greffe.. The Mouseion at the JAXlibrary (Jackson Laboratory).1 indexed citations
17.
Mathé, G, et al.. (1961). Etude des agglutinines seriques contre un antigene bacterien chez des radiochimeres hematologiques immunisees contre l'antigene avant l'irradiation.. The Mouseion at the JAXlibrary (Jackson Laboratory).3 indexed citations
18.
Mathé, G, et al.. (1960). Traitement de souris akr a l'age de six mois par irradiation totale suivie de transfusion de cellules hematopoietiques allogeniques. Incidences respectives de la leucemie et du syndrome secondaire.. The Mouseion at the JAXlibrary (Jackson Laboratory).1 indexed citations
19.
Mathé, G, et al.. (1959). [Transfusion and graft of bone marrow in man: technic].. PubMed. 30. 784–8.
20.
Bernard, J & G Mathé. (1954). [Practical treatment of acute leukosis].. PubMed. 4(15). 1379–82.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.